Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Osteoporosis

  Free Subscription


04.10.2021

4 J Bone Miner Res
3 J Clin Endocrinol Metab
2 Osteoporos Int
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    J Bone Miner Res

  1. BLACK DM, Reid IR, Napoli N, Ewing SK, et al
    The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
    J Bone Miner Res. 2021 Sep 28. doi: 10.1002/jbmr.4434.
    PubMed         Abstract available

  2. SKULADOTTIR SS, Ramel A, Eymundsdottir H, Hjaltadottir I, et al
    Serum 25-hydroxy-vitamin D status and incident hip fractures in elderly adults: Looking beyond bone mineral density.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4450.
    PubMed        

  3. BANEFELT J, Timoshanko J, Soreskog E, Ortsater G, et al
    Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4448.
    PubMed         Abstract available

  4. GREY A, Bolland MJ, Horne A, Mihov B, et al
    Bone mineral density and bone turnover ten years after a single 5mg dose or two 5-yearly lower doses of zoledronate in osteopenic older women: an open-label extension of a randomized controlled trial.
    J Bone Miner Res. 2021 Sep 29. doi: 10.1002/jbmr.4453.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  5. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    PubMed         Abstract available

  6. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    PubMed        

  7. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    PubMed        


    Osteoporos Int

  8. LESLIE WD, Yan L, Lix LM, Morin SN, et al
    Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study.
    Osteoporos Int. 2021 Sep 25. pii: 10.1007/s00198-021-06166.
    PubMed         Abstract available

  9. MOLLER S, Skjodt MK, Yan L, Abrahamsen B, et al
    Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
    Osteoporos Int. 2021 Oct 1. pii: 10.1007/s00198-021-06165.
    PubMed         Abstract available


    PLoS One

  10. WILLIAMS SA, Greenspan SL, Bancroft T, Chastek BJ, et al
    Development and validation of a one year predictive model for secondary fractures in osteoporosis.
    PLoS One. 2021;16:e0257246.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: